ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Faden, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Faden, H.

Ann Thorac Surg 1981;31:211-213
© 1981 The Society of Thoracic Surgeons

Articles

Prophylactic Antibiotics in Pediatric Cardiovascular Surgery: Current Practices

Howard Faden, M.D.*

State University of New York at Buffalo, and Children's Hospital, Division of Infectious Diseases and Virology, Buffalo, NY

Accepted for publication August 6, 1980.

* Address reprint requests to Dr. Faden, Children's Hospital, Division of Infectious Diseases and Virology, 219 Bryant St, Buffalo, NY 14222

A survey of 23 pediatric cardiovascular surgery programs demonstrated uniform use of prophylactic antibiotics for open-heart operations. Only 65% of the programs used prophylaxis for repair of patent ductus arteriosus. Cephalosporins were the most frequently used antibiotics, but aminoglycosides in combination with penicillins were used in approximately 25% of the operations. Antibiotics were most often started prior to operation (89.7%) and continued for less than five days. These data demonstrate that the use of prophylaxis in pediatric cardiovascular operations conforms to current guidelines.




This article has been cited by other articles:


Home page
 Am J Health Syst PharmHome page
C. A. Knoderer, E. G. Cox, M. D. Berg, A. H. Webster, and M. W. Turrentine
Efficacy of limited cefuroxime prophylaxis in pediatric patients after cardiovascular surgery
Am. J. Health Syst. Pharm., May 15, 2011; 68(10): 909 - 914.
[Abstract] [Full Text] [PDF]

Home page
 Asian Cardiovasc. Thorac. Ann.Home page
W. Mrowczynski, M. Wojtalik, D. Zawadzka, G. Sharma, J. Henschke, R. Bartkowski, M. Pawelec-Wojtalik, A. Wodzinski, and P. Westerski
Infection Risk Factors in Pediatric Cardiac Surgery
Asian Cardiovasc Thorac Ann, December 1, 2002; 10(4): 329 - 333.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
K. O. Maher, K. VanDerElzen, E. L. Bove, R. S. Mosca, C. E. Chenoweth, and T. J. Kulik
A retrospective review of three antibiotic prophylaxis regimens for pediatric cardiac surgical patients
Ann. Thorac. Surg., October 1, 2002; 74(4): 1195 - 1200.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
T. A. Raab, S. Balderman, J. Bhayana, K. Bingham, J. Mylotte, and T. R. Beam Jr.
A Comparison of the Safety, Efficacy, and Distribution of Ceforanide and Cephalothin in Coronary Artery Bypass Graft Surgery
Ann. Thorac. Surg., April 1, 1982; 33(4): 340 - 344.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1981 by The Society of Thoracic Surgeons.